ASVAC 2017
Meet The Speakers
Bruce
Mr Bruce Langoulant

Read More


Mr Bruce Langoulant is the parent and co – carer of an adult daughter with multiple disabilities caused by pneumococcal meningitis. He is Chairperson of the Disability Services Commission of Western Australia , Chairperson of Meningitis Centre Australia , Vice President Asia Pacific Region of the International Confederation of Meningitis Organisations Ltd and an advocate for vaccine access to protect all from meningitis.

Read Less

Daniel-Payne
Daniel Payne, USA
US Centers for Disease Control and Prevention

Read More

Dr. Daniel C. Payne is an epidemiologist and Senior Scientific Advisor in the Division of Viral Diseasesat the US Centers for Disease Control and Prevention. 

He is the Principal Investigator for a primary, multi-site active surveillance network for both acute gastroenteritis and acute respiratory illnesses in children in the US.

Read Less

De-La-Vega
Shelley Ann F. De la Vega, MD, MSc, FPCGM Philippines
Institute on Aging – National Institutes of Health

Read More


Dr. Shelley de la Vega is a Professor of the Department of Medicine, University of the Philippines College of Medicine and founding Director of the Institute on Aging, University of the Philippines Manila – National Institutes of Health. She is the Vice President of the Philippine Foundation for Vaccination. She assists the Department of Health, DSWD, National Academy of Science and Technology and various NGOs as technical consultant.
Dr. De la Vega completed her BS Psychology, cum laude at the University of the Philippines Diliman and Doctor of Medicine, University of the Philippines College of Medicine, Manila. She trained in Internal Medicine at the State University of New York (Downstate), after which she served as Chief Resident. She completed a 2-year Fellowship in Geriatric Medicine at the Division on Aging, Harvard Medical School, Boston, USA. She received her board certificate in Internal Medicine and Geriatric Medicine from the American Board of Internal Medicine. She completed her Master of Science in Clinical Epidemiology at the University of the Philippines Manila.
As a teacher, she has been responsible for incorporating geriatrics in the medical curriculum of the UP College of Medicine. She teaches medical students, Internal Medicine residents and fellows. She has given talks on themes on aging and non-communicable diseases to almost all major physician, nursing and allied medical societies in the Philippines. She was the organizer of the first International Conference on Longevity and Public Health in Manila; the Asia-Pacific Geriatric Conference in Cebu; and the National Conferences on Aging in Tacloban Leyte and Panay. She also enjoys being a lay educator to various citizens’ organizations, and is a frequent guest in television and radio talk shows.
She assists the Department of Health, DSWD, National Academy of Science and Technology and various NGOs as technical consultant. She was the Chairperson of the Committee on Aging and Degenerative Diseases (COMADD), and the former Director of the Institute of Health Policy and Development Studies National Institutes of Health. She is also a member of the National Advisory Council on Active Aging (NAST). She is a founding director of the Alzheimer’s disease Association of the Philippines and is the Vice President of the Philippine Foundation for Vaccination. She has published local and international journal articles, book chapters, monographs, as well as policy documents on Geriatric healthcare services, vaccination, Alzheimer’s Disease management, healthcare financing and education.
Dr. Shelley is the first president of Philippine College of Geriatric Medicine, which was formed in 2011 after the merging of 2 existing Geriatric Medicine Societies of the Philippine Medical Association and Philippine College of Physicians. She is the founding Director for The Center of Healthy Aging, and the former Chief of the Section of Geriatrics at The Medical City Ortigas. She pioneered the establishment of the first Geriatric Multidisciplinary Outpatient Clinic in the Philippines at the Philippine General Hospital.

Read Less

Christopher
Christopher Head
MA FRSA MInstF

Read More

Chris Head is President of the international Confederation of Meningitis Organisations (CoMO), and a member of the Steering Committee of the Global Meningococcal Initiative. From 2007–2015 Chris was a trustee of Action Meningitis Malawi, and CEO of the Meningitis Research Foundation, which played a leading role in developing and campaigning for a vaccine against meningococcal meningitis type B, which was approved for inclusion in the UK’s infant vaccination schedule in September 2015. During this period he was also a member of the steering committee of the Meningitis Free World Initiative and an adviser to the Excellence in Paediatrics institute.

Chris has nearly 25 years’ experience in leadership of health organizations in the voluntary sector, including CEO roles at CLIC UK and Penny BrohnCancer Care.A long-standing member of the Institute of Fundraising, Chris was also a board member and Treasurer of the Association of Chief Executives of Voluntary Organisations, Chair of the Cancer Care Charities Partnership, and an advisory panel member for United Bristol NHS Healthcare Trust.                                                                                   

Confederation of Meningitis Organisations
The Confederation of Meningitis Organisations Inc. (CoMO) is an international member organization working to reduce the incidence and impact of meningitis worldwide. CoMO brings together patient groups, health professionals and organizations, meningitis survivors and families from more than 25 countries to help prevent meningitis through raising public awareness of meningitis through education, and advocating for vaccines to be available to families worldwide. CoMO also connects and resources a strong global network of members who make sure their communities have access to meningitis information and support.
http://www.comomeningitis.org/

Read Less

William
William Hausdorff, Belgium

Read More


Bill has worked to expedite the development and introduction of new and improved vaccines for over 25 years, first with the US Centers for Disease Control and Prevention and later at Wyeth and GSK Vaccines. In addition to facilitating the development of the current pneumococcal conjugate vaccines, he is the author of extensive publications on the epidemiology and prevention of S. pneumoniae disease.

William (Bill) Hausdorff has worked on the development, testing, registration, implementation and evaluation of a variety of pediatric vaccines for over 25 years.  He currently is an independent consultant, based in Brussels, Belgium.
He most recently worked with GlaxoSmithKline Vaccines, serving as Vice President, Scientific Affairs & Public Health, as Vaccine Development Leader, Pneumococcal Vaccines and as Director, Epidemiology & Scientific Strategy.
Previously employed by Wyeth Vaccines in the Scientific Affairs & Research Strategy group, he co-holds patents on the design of the 13-valent pneumo-coccal conjugate vaccine, receiving no royalties as is industry practice.
He has alsoserved as a Technical Advisor with the US Centers for Disease Control & Prevention, based at the US Agency for International Development in Washington DC and Cairo, Egypt.  There he worked to expedite introduction of new vaccines into developing country immunization programs.
He received a PhD in Biology from Johns Hopkins Univ./U.S. National Institutes of Health, with a post-doctoral fellowship in molecular pharmacology at Duke Univ.  He is the author of numerous scientific articles and book chapters, including extensive publications on the epidemiology and prevention of S. pneumoniaedisease.

Read Less

John
Prof. John S. Tam, Ph.D.
Chairman and Director
Asia Pacific Alliance for the Control of Influenza (APACI).

Read More


Visiting Professor,
Department of Applied Biology and Chemical Technology
The Hong Kong Polytechnic University.

Prior to joining the Hong Kong Polytechnic University, Prof. Tam had worked as Technical Officer of the Initiative for Vaccine Research at the World Health Organization (WHO), Geneva, and was responsible for the global research and development of seasonal and pandemic influenza vaccines as well as the focal point for influenza policy development under SAGE. He also served as Scientist at the Global Influenza Programme of WHO, Geneva and was responsible for the development and implementation of the WHO Public Health Research Agenda for Influenza. John also worked in a leading role in the pharmaceutical industry on vaccine research and development. Prior to these, he was Professor in the Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong for 18 years. Dr. Tam received his B.Sc. and M.Sc. degrees from the University of Toronto majoring in virology, microbiology and biochemistry, and his Ph.D. degree from the University of Hong Kong on virology. John has been active in the field of medical virology and his interest included influenza and other viral respiratory tract infections, viral diarrhoeal diseases, viral hepatitis and virus-associated cancers. He had published over 180 peer-reviewed articles relating to his fields of interest.

Read Less

Carl
Carl Kirkwood, Australia
Bill and Melinda Gates Foundation, USA.

Read More


Carl Kirkwood, PhD, is a Senior Program Officer in the Enteric and Diarrheal Diseases program, in the Global Health Division of the Bill and Melinda Gates Foundation, and leads the rotavirus initiative. Prior to joining the Foundation, Dr Kirkwood was group leader of the Enteric Virus Group, Murdoch Childrens Research Institute, which is co-located at The Royal Children’s Hospital, Australia. His research focused on infectious diseases of the gastrointestinal tract, specifically diarrheal disease caused by rotavirus and norovirus.

Read Less

Kim
Kim Mulholland, Australia
Kim Mulholland MBBS, FRACP, MD, Professorial Fellow,
Group Leader, Murdoch Childrens Research Institute

Read More


Kim Mulholland is an Australian paediatrician, trained at Melbourne University and the Royal Children’s Hospital, Melbourne. With post-graduate training in immunology, respiratory medicine and tropical medicine he joined the Medical Research Council Laboratories in 1989, where he developed a program of research covering all aspects of the problem of childhood pneumonia. This included studies of the aetiology, clinical signs, and treatment of pneumonia cases, with particular reference to very young infants and malnourished children. These studies guided WHO policy in the field and contributed to the development of the strategy of Integrated Management of Childhood Illness (IMCI), as well as guiding oxygen and antibiotic management for hospitalized children. His Hib vaccine trials were the first to demonstrate the capacity of conjugate vaccines to prevent bacterial pneumonia, and paved the way for Hib vaccine introduction in Africa. After six years in the Gambia he joined WHO where he oversaw the development of standardized methods for the evaluation of pneumonia vaccines in developing countries. Since leaving WHO in 2000 he has continued to work in the pneumonia field with particular emphasis on vaccines. He was one of the founders of the Global Action Plan for Pneumonia, and one of the leaders of the successful Hib Initiative project that saw the introduction of Hib vaccines into the poorest countries of the world. During the same period he established leading pneumococcal microbiology and immunology laboratories at the Murdoch Children’s Research Institute (MCRI), Melbourne, along with major field research programs in Vietnam, Fiji and Mongolia, and growing programs in Indonesia and Laos. He currently holds professorial appointments at the MCRI in Melbourne and the London School of Hygiene and Tropical Medicine in UK.

Read Less

VIDOR
VIDOR Emmanuel, France
Sanofi Pasteur

Read More


As a co-author of the “Poliovirus Vaccine – Inactivated” chapter of the “Vaccines” book since several editions, has been able to follow the evolution of the topic since more than 20 years, and is able to provide an industrial perspective from one of the main suppliers of IPV-containing vaccines.

Biography:
Working in the vaccine industry since 30 years and having held several positions within Sanofi Pasteur (and its ancestral companies) in R&D as Project Leader for several vaccines under development and as responsible of the Clinical Development Programs of several vaccines under development. Since 2010, works as an expert within Medical Affairs.
Graduated in Medicine (1983, Lyon, France), in Tropical Medicine (1983, Lyon, France), in Biostatistics (1984, Villejuif, France) and obtained a Master in Biological and Medical Sciences (1985, Lyon, France). Followed the Applied Epidemiology course in 1986 (IES CDC program, Veyrier du Lac, France).

Read Less

Mathuram
Mathuram Santosham, USA
Johns Hopkins Bloomberg School of Public Health, Department of International Health

Read More

Dr. Mathuram Santosham was born in Vellore, India and obtained his MBBS degree from the Jawaharlal Institute of Post Graduate Medical Education and Research in Pondicherry, India in 1970. He subsequently moved to the US and obtained Board Certification in Pediatrics and an MPH degree from the Johns Hopkins University. He also completed a Fellowship in Pediatric Infectious Diseases at Johns Hopkins Hospital.

Dr. Santosham was  the Founder and Director of the Johns Hopkins Center for American Indian Health f(CAIH) rom April 1991 to April 2016.  He is currently the Director Emeritus of CAIH. He holds Professorships in the Department of International Health and the Department of Pediatrics at Johns Hopkins University. He directed the Division of Health Systems for the Johns Hopkins Bloomberg School of Public Health from 2000-2009.

Dr. Santosham is internationally known for his work on oral rehydration therapy, childhood vaccines and dissemination of pediatric prophylactics to vulnerable populations worldwide. Working in partnership with Native American communities, he conducted landmark vaccine efficacy trials, including rotavirus vaccine, H. influenzae type b (Hib) conjugate vaccine, and pneumococcal conjugate vaccine. Native American children used to die from these diseases at rates 10 to 50 times the US average. Through his advocacy, these vaccines now save 3 to 5 million lives a year in the US and across the globe. In addition, Dr. Santosham worked with the White Mountain Apache Tribe to pioneer the use of oral rehydration solution (ORS), now known as “Pedialyte” in the US. Based on this evidence, ORS has become the standard of care for treating diarrheal dehydration, and is credited with saving 60 million lives since 1980. Dr. Santosham has become a global leader in the national and international dissemination of these public health strategies worldwide.

Dr. Santosham serves on numerous national and international committees to promote childhood health throughout the world. He consults for numerous international agencies including WHO, USAID, UNICEF and the Gates Foundation on aspects of child survival in over 30 countries. He is

the author of over 270 peer-reviewed journals and serves as a reviewer for several international medical journals. He is the recipient of numerous awards including the Thrasher Research Fund Award for Excellence in Research (1988), Maurice Hilleman Lecturer at CDC (2008), and the Bob Austrian Orator, for International Symposium on Pneumococcas and Pneumococcal Disease (2006). He was also awarded the Indian Health Service Directors Award for Career Service in 2011, recognizing his personal dedication, commitment and contribution to the overall Indian Health Service Research Program and the global impact of his work. He  received the Albert Sabin Gold Medal Award (http://www.sabin.org/updates/events/2014-albert-b-sabin-gold-medal-award) on April 29th 2014.  The Albert B. Sabin Gold Medal has been awarded annually since 1994 to a distinguished member of the research community who has made extraordinary contributions in the field of Vaccine sciences  or a complementary field.  On Oct 7th 2014, he  received the 2014 Fries Prize for Improving Health, “For his seminal research, vaccine development, policy, and advocacy toward the global prevention of Haemophilus influenza type b (Hib) disease saving each year more than 370,000 children’s lives (www.cdcfoundation.org/pr/2014/mathuram-santosham-receives-2014-fries-prize-improving-health). He is currently the chair of the ROTA council (http://rotacouncil.org) which is an organization that is dedicated to advocating for the use  of rotavirus vaccines around the world particularly in Asia and Africa.

Read Less


© ASVAC 2017 | All Rights Reserved | Sitemap

Organized by:



Managed by:



c/o Kenes Asia (Thailand) Co., Ltd.
PICO Building, 10 Soi Lasalle 56, Sukhumwit
Bangna, Bangkok 10260
Thailand
Tel: +662 7487881
Fax: +662 7487880
Email: asvac2017@kenes.com